4.6 Article

Effect of N-acetylcysteine on Cycling Performance after Intensified Training

Journal

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
Volume 46, Issue 6, Pages 1114-1123

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1249/MSS.0000000000000222

Keywords

ANTIOXIDANT; OXIDATIVE STRESS; INFLAMMATION; NUCLEAR FACTOR kappa B

Categories

Funding

  1. Australian Institute of Sport
  2. New South Wales Institute of Sport

Ask authors/readers for more resources

Purpose: This investigation examined the ergogenic effect of short-term oral N-acetylcysteine (NAC) supplementation and the associated changes in redox balance and inflammation during intense training. Methods: A double-blind randomized placebo-controlled crossover design was used to assess 9 d of oral NAC supplementation (1200 mg.d(-1)) in 10 well-trained triathletes. For each supplement trial (NAC and placebo), baseline venous blood and urine samples were taken, and a presupplementation cycle ergometer race simulation was performed. After the loading period, further samples were collected preexercise, postexercise, and 2 and 24 h after the postsupplementation cycle ergometer race simulation. Changes in total antioxidant capacity, ferric reducing ability of plasma, reduced glutathione, oxidized glutathione, thiobarbituric acid-reactive substances, interleukin 6, xanthine oxidase, hypoxanthine, monocyte chemotactic protein 1, nuclear factor kappa B, and urinary 15-isoprostane F-2t concentration were assessed. The experimental procedure was repeated with the remaining supplement after a 3-wk washout. Eight participants completed both supplementation trials. Results: NAC improved sprint performance during the cycle ergometer race simulation (P < 0.001, eta(2)(p) = 0.03). Supplementation with NAC also augmented postexercise plasma total antioxidant capacity (P = 0.005, eta(2)(p) = 0.19), reduced exercise-induced oxidative damage (plasma thiobarbituric acid-reactive substances, P = 0.002, eta(2)(p) = 0.22; urinary 15-isoprostane F2t concentration, P = 0.010, eta(2)(p) = 0.431), attenuated inflammation (plasma interleukin 6, P = 0.002, eta(2)(p) = 0.22; monocyte chemotactic protein 1, P = 0.012, eta(2)(p) = 0.17), and increased postexercise nuclear factor kappa B activity (P < 0.001, eta(2)(p) = 0.21). Conclusion: Oral NAC supplementation improved cycling performance via an improved redox balance and promoted adaptive processes in well-trained athletes undergoing strenuous physical training.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available